Journal
ONCOTARGETS AND THERAPY
Volume 11, Issue -, Pages 6879-6886Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OTT.S177605
Keywords
hypoxia; osteosarcoma; carbonic anhydrase IX; inhibitor
Categories
Ask authors/readers for more resources
Purpose: We investigated the effect of carbonic anhydrase IX (CA IX) inhibitor under hypoxia and normoxia in SaOS2 human osteosarcoma cell line. We also evaluated the expression of CA IX in 27 patients diagnosed with osteosarcoma. Materials and methods: CA IX expression in SaOS2 cells cultured under different oxygen tensions was analyzed by Western blotting. To evaluate the effect of CA IX inhibitor, MTS cell viability assay was performed after cells were treated with various concentrations of doxorubic in with or without a CA IX inhibitor. Finally, CA IX expression in patient-derived osteosarcoma samples was evaluated by immunohistochemistry. Results: Treatment with CA IX inhibitor significantly suppressed cell proliferation and migration under hypoxic conditions. CA IX expression was observed in 81% of 27 patients. The 5-year survival rates in patients with high and low stain scores were 43.8% and 81.8%, respectively. Conclusion: CA IX inhibitors have the potential to suppress cell proliferation, migration, and chemoresistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available